Search Results - "Rubin, D T"

Refine Results
  1. 1

    Real‐world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease by Rubin, D. T., Mody, R., Davis, K. L., Wang, C.‐C.

    Published in Alimentary pharmacology & therapeutics (01-05-2014)
    “…Summary Background Treatments for Crohn's disease (CD) and ulcerative colitis (UC) are not uniformly effective, thus necessitating dose changes, switching, and…”
    Get full text
    Journal Article
  2. 2

    Randomised clinical trial: delayed‐release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing – ASCEND I and II combined analysis by Lichtenstein, G. R., Ramsey, D., Rubin, D. T.

    Published in Alimentary pharmacology & therapeutics (01-03-2011)
    “…Aliment Pharmacol Ther 2011; 33: 672–678 Summary Background  Recent studies have focused on the importance of mucosal healing in ulcerative colitis (UC)…”
    Get full text
    Journal Article
  3. 3

    Systematic review: impact of non‐adherence to 5‐aminosalicylic acid products on the frequency and cost of ulcerative colitis flares by HIGGINS, P. D. R., RUBIN, D. T., KAULBACK, K., SCHOENFIELD, P. S., KANE, S. V.

    Published in Alimentary pharmacology & therapeutics (01-02-2009)
    “…Summary Background  Ulcerative colitis (UC) can be maintained in remission with 5‐aminosalicylic acid (5‐ASA) medications, but frequent non‐adherence by…”
    Get full text
    Journal Article
  4. 4

    Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease by Kisiel, J. B., Yab, T. C., Nazer Hussain, F. T., Taylor, W. R., Garrity‐Park, M. M., Sandborn, W. J., Loftus, E. V., Wolff, B. G., Smyrk, T. C., Itzkowitz, S. H., Rubin, D. T., Zou, H., Mahoney, D. W., Ahlquist, D. A.

    Published in Alimentary pharmacology & therapeutics (01-03-2013)
    “…Summary Background Current approaches to the detection of colorectal neoplasia associated with inflammatory bowel disease (IBD‐CRN) are suboptimal. Aim To test…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease—Authors’ reply by Christensen, B., Gibson, P. R., Rubin, D. T.

    Published in Alimentary pharmacology & therapeutics (01-05-2018)
    “…Linked Content This article is linked to Christensen et al and Pavlidis et al papers. To view these articles visit https://doi.org/10.1111/apt.14525 and…”
    Get full text
    Journal Article
  8. 8

    Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial by Feagan, B. G., Patel, H., Colombel, J.‐F., Rubin, D. T., James, A., Mody, R., Lasch, K.

    Published in Alimentary pharmacology & therapeutics (01-01-2017)
    “…Summary Background Health‐related quality of life (HRQL) is often diminished in patients with ulcerative colitis. Aim To evaluate the effects of vedolizumab on…”
    Get full text
    Journal Article
  9. 9

    Smoking and inflammatory bowel disease by Rubin, D T, Hanauer, S B

    “…It is well established that smoking cigarettes is associated with Crohn's disease (CD) and that non-smoking is associated with ulcerative colitis (UC)…”
    Get more information
    Journal Article
  10. 10

    CT colonography with three-dimensional problem solving for detection of colonic polyps by Dachman, AH, Kuniyoshi, JK, Boyle, CM, Samara, Y, Hoffmann, KR, Rubin, DT, Hanan, I

    Published in American journal of roentgenology (1976) (01-10-1998)
    “…We performed CT colonography in patients referred for conventional colonoscopy, interpreted the axial images, and used commercially available software to…”
    Get full text
    Journal Article
  11. 11

    Ethics of a Paired-Kidney-Exchange Program by Ross, Lainie Friedman, Rubin, David T, Siegler, Mark, Josephson, Michelle A, Thistlethwaite, J. Richard, Woodle, E. Steve

    Published in The New England journal of medicine (12-06-1997)
    “…Although transplantation is the best treatment for many people with end-stage renal disease, the gap between the number of organ donors and the number of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts by Bezabeh, T., Somorjai, R., Dolenko, B., Bryskina, N., Levin, B., Bernstein, C. N., Jeyarajah, E., Steinhart, A. H., Rubin, D. T., Smith, I. C. P.

    Published in NMR in biomedicine (01-07-2009)
    “…Colorectal cancer is one of the most common cancers in the western world. Its early detection has been found to improve the prognosis of the patient, providing…”
    Get full text
    Journal Article
  14. 14
  15. 15

    P221 Intestinal ultrasound is predictive of disease relapse in asymptomatic Inflammatory Bowel Disease patients by Picker, E A, Choi, N K, Reddy, N, Rubin, D T, Krugliak Cleveland, N

    Published in Journal of Crohn's and colitis (24-01-2024)
    “…Abstract Background Intestinal ultrasound (IUS) is a non-invasive, repeatable, and accurate disease monitoring modality that provides real-time assessment of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    P543 Patients in trials of moderate-to-severe UC who are exposed to placebo are more likely to suffer harm than those receiving active treatment: The lack of clinical equipoise in traditional study designs by Fine, Z, Fear, E N, St-Pierre, J, Klein, J A, Choi, N K, Rubin, D T

    Published in Journal of Crohn's and colitis (24-01-2024)
    “…Abstract Background Ulcerative Colitis (UC) is a relapsing-remitting inflammatory disease of the colon and rectum. There are many challenges to the recruitment…”
    Get full text
    Journal Article
  18. 18

    P787 Use of upadacitinib to treat IBD in post-liver transplant by Miyatani, Y, Choi, D, Choi, N K, Aronsohn, A I, Pillai, A, Cohen, R D, Rubin, D T

    Published in Journal of Crohn's and colitis (24-01-2024)
    “…Abstract Background Approximately 2% of patients with inflammatory bowel disease (IBD) have concurrent primary sclerosing cholangitis (PSC). Liver…”
    Get full text
    Journal Article
  19. 19

    P982 Patients in trials of moderate-to-severe CD who are exposed to placebo are more likely to suffer harm than those receiving active treatment: The lack of clinical equipoise in traditional study designs by Fear, E, Fine, Z D, St-Pierre, J, Klein, J A, Choi, N K, Rubin, D T

    Published in Journal of Crohn's and colitis (24-01-2024)
    “…Abstract Background Crohn’s disease (CD) is a relapsing-remitting inflammatory disease of the gastrointestinal tract characterized by a progressive nature and…”
    Get full text
    Journal Article
  20. 20

    Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study by Kappelman, Michael D, Horvath-Puho, Erzsebet, Sandler, Robert S, Rubin, David T, Ullman, Thomas A, Pedersen, Lars, Baron, John A, Sørensen, Henrik T

    Published in Gut (01-07-2011)
    “…Recommendations for venous thromboembolism (VTE) prophylaxis in patients with inflammatory bowel disease (IBD) can be refined by incorporating patient-specific…”
    Get more information
    Journal Article